Berkenblit Anna
Related Filers (2)
Other (18)
144
Wednesday, 9/13/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 9/11/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 9/6/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 9/1/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 8/31/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 8/30/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 8/29/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 8/28/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 8/25/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 8/24/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 8/23/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 8/22/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 8/21/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 8/18/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 8/17/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 8/16/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 8/15/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 8/14/2023
Filing for proposed sale of securities under Rule 144
Ownership (27)
4
Wednesday, 7/5/2023
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/22/2023
Surrozen, Inc./DE: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/7/2023
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/3/2023
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/27/2022
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/5/2022
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/9/2022
Surrozen, Inc./DE: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/8/2022
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/4/2022
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 8/16/2021
Surrozen, Inc./DE: Initial statement of beneficial ownership of securities
4
Friday, 7/2/2021
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/9/2021
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/5/2021
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/2/2020
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/25/2020
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/11/2020
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/2/2019
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Monday, 2/25/2019
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Monday, 2/4/2019
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Friday, 1/4/2019
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/17/2018
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/11/2018
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Friday, 2/23/2018
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/20/2018
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Monday, 9/18/2017
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Thursday, 2/23/2017
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
3
Friday, 12/16/2016
IMMUNOGEN INC: Initial statement of beneficial ownership of securities